Cap on trade margin of 42 non-scheduled cancer drugs by NPPA led to up to 90 pc reduction in MRP: Mansukh Mandaviya https://ift.tt/eA8V8J

"The total annual savings on account of revision of ceiling prices of medicines under the National List of Essential Medicines (NLEM), price control of anti-diabetic and cardiovascular, fixation of ceiling price of stents, knee implants and capping of TMR on anti-cancer are estimated to the tune of Rs 12,500 crore," Mansukh Mandaviya said.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3xvebRq